Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Significant improvements in targeted UHPLC-ESI-MS/MS analysis of the reactive aldehydes 4-hydroxy-2(E)-nonenal and 4-hydroxy-2(E)-hexenal and application to rat serum.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2025
Same author

Signature of anyonic statistics in the integer quantum Hall regime.

Nature communications·2024
Same author

Observation of the scaling dimension of fractional quantum Hall anyons.

Nature·2024
Same author

Author Correction: Quasiparticle Andreev scattering in the ν = 1/3 fractional quantum Hall regime.

Nature communications·2024
Same author

Observing the universal screening of a Kondo impurity.

Nature communications·2023
Same author

Quasiparticle Andreev scattering in the ν = 1/3 fractional quantum Hall regime.

Nature communications·2023

Related Experiment Video

Updated: Jun 12, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

[Late prognosis after preeclampsia].

O Pourrat1, F Pierre

  • 1Consultation de médecine interne, service de réanimation médicale et médecine interne, CHU et université de Poitiers, 2, rue de la Milétrie, BP 577, 86021 Poitiers, France. o.pourrat@chu-poitiers.fr

Annales Francaises D'Anesthesie Et De Reanimation
|May 22, 2010
PubMed
Summary
This summary is machine-generated.

The risk of preeclampsia relapse is under 10%, but higher with early onset. Investigations for underlying conditions and long-term follow-up are crucial for managing subsequent pregnancies and preventing future cardiovascular issues.

More Related Videos

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
05:31

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Published on: January 26, 2024

Related Experiment Videos

Last Updated: Jun 12, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
05:31

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Published on: January 26, 2024

Area of Science:

  • Obstetrics and Gynecology
  • Nephrology
  • Cardiovascular Medicine

Context:

  • Preeclampsia, eclampsia, and HELLP syndrome are severe pregnancy complications with significant maternal and fetal morbidity/mortality.
  • Understanding relapse risk is critical for managing subsequent pregnancies and patient care.

Purpose:

  • To outline the prognosis and relapse risk of severe pregnancy complications.
  • To guide clinical management, including necessary investigations and long-term follow-up strategies.

Summary:

  • Overall relapse risk for preeclampsia is <10%, increasing with early onset (<28 weeks).
  • Early-onset cases may indicate underlying renal disease, hypertension, or thrombophilia, requiring thorough postpartum investigation.
  • Severe preeclampsia signifies vascular disease and is a risk factor for future atherosclerosis and cardiovascular complications.

Impact:

  • Informs clinical decision-making for patients with a history of severe pregnancy complications.
  • Highlights the need for comprehensive postpartum evaluation and long-term monitoring for cardiovascular, renal, and metabolic health.
  • Emphasizes the importance of identifying underlying conditions to optimize maternal and fetal outcomes in future pregnancies.